Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1074 studies found for:    "Hepatitis C, Chronic"
Show Display Options
RSS Create an RSS feed from your search for:
"Hepatitis C, Chronic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Evaluation of Irbesartan on Hepatic Fibrosis in Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Irbesartan;   Drug: placebo
2 Completed
Has Results
Three Regimens of PegIntron Plus Ribavirin in Previously Untreated Chronic Hepatitis C, Genotype 2 or 3 (Study P03548)
Condition: Hepatitis C, Chronic
Interventions: Biological: peginterferon alfa-2b (SCH 54031);   Drug: ribavirin (SCH 18908)
3 Completed Multidisciplinary Support Program in Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Other: Multidisciplinary support program
4 Completed A Study to Assess the Efficacy and Safety of the Combination of Simeprevir and Daclatasvir in Chronic Hepatitis C Genotype 1b-Infected Participants
Condition: Hepatitis C, Chronic
Interventions: Drug: Simeprevir;   Drug: Daclatasvir
5 Completed Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Peg-interferon alpha 2a (drug);   Drug: Ribavirin (drug);   Drug: Interferon gamma (drug)
6 Active, not recruiting Phase I Trial to Evaluate the Safety, Tolerability and Immunogenicity of VGX-6150 for Second-line Therapy of Chronic Hepatitis C Infection
Condition: Hepatitis C, Chronic
Intervention: Biological: VGX-6150
7 Completed Evaluating Silymarin for Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Drug: Silymarin (milk thistle)
8 Completed Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects
Condition: Hepatitis C, Chronic
Interventions: Drug: GSK2336805;   Drug: Pegylated interferon alfa-2a;   Drug: Ribavirin;   Drug: GSK2336805 Matching Placebo
9 Completed A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation
Condition: Hepatitis C, Chronic
Interventions: Drug: Simeprevir;   Drug: Daclatasvir;   Drug: Ribavirin;   Drug: Cyclosporine;   Drug: Tacrolimus
10 Recruiting Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection
Condition: Hepatitis C, Chronic
Interventions: Drug: AL-335;   Drug: Odalasvir;   Drug: Simeprevir
11 Active, not recruiting An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease
Condition: Hepatitis C, Chronic
Interventions: Drug: Simeprevir;   Drug: Daclatasvir;   Drug: Sofosbuvir
12 Completed Study to Assess the Safety, Pharmacokinetics, and Antiviral Activity of Repeat Doses of GSK2878175 in Subjects With Chronic Hepatitis C.
Condition: Hepatitis C, Chronic
Interventions: Drug: GSK2878175;   Drug: Placebo
13 Recruiting Efficacy and Safety of Daclatasvir Plus Asunaprevir in Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention: Drug: Daclinza and Sunvepra
14 Completed
Has Results
Treatment of Chronic Hepatitis C With Pegylated Interferon and Ribavirin in Participants With/Without Substitution Therapy (P05255)
Condition: Hepatitis C, Chronic
Interventions: Biological: Pegylated interferon alfa-2b (PegIFN-2b);   Drug: Ribavirin
15 Terminated Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Drug: Viramidine;   Drug: Peginterferon alfa-2b
16 Completed Viral Kinetics and Liver Gene Expression in Response to Ribavirin and Peginterferon Therapy of Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Interventions: Procedure: Liver Biopsy;   Drug: Peginterferon & Ribavirin for Hepatitis C;   Drug: Pre-treatment Ribavirin
17 Terminated
Has Results
Pharmacokinetics of Boceprevir in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P07614)
Condition: Hepatitis C, Chronic
Intervention: Drug: Boceprevir
18 Terminated
Has Results
The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833)
Condition: Hepatitis C, Chronic
Interventions: Biological: PegIntron (peginterferon alfa-2b);   Drug: Rebetol (ribavirin)
19 Completed
Has Results
A Retrospective Study of Real World Treatment Outcomes of Patients With Chronic Hepatitis C
Condition: Hepatitis C, Chronic
Intervention:
20 Completed
Has Results
Study of PEG-Intron Plus REBETOL in Pediatric Subjects With Chronic Hepatitis C (Study P02538 Part 1)
Condition: Hepatitis C, Chronic
Interventions: Biological: peginterferon alfa-2b (PEG2b) (SCH 54031);   Drug: ribavirin (SCH 18908)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.